1. Home
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Global Dialysis Market: Analysis By Number of Patients, By Product & Services, By Type, By End-User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

Global Dialysis Market: Analysis By Number of Patients, By Product & Services, By Type, By End-User, By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027

  • October 2022
  • 224 pages
  • ID: 6351423
  • Format: PDF
  • Daedal Research

Summary

Table of Contents

The global dialysis market was valued at US$98.30 billion in 2021. The market value is expected to reach US$130.23 billion by 2027. Dialysis is a procedure to remove waste products and excess fluid from the blood when the kidneys stop working properly. It often involves diverting blood to a machine to be cleaned. Dialysis prevents the waste products in the blood from reaching hazardous levels. It can also remove toxins or drugs from the blood in an emergency setting.

The factors such as the growing number of patients suffering from diabetes, increasing healthcare expenditure and rising awareness regarding kidney diseases and their treatment are expected to drive the overall market growth in the forecasted period. The market is expected to grow at a CAGR of approx. 4.8% during the forecasted period of 2022-2027.

Market Segmentation Analysis:

By Product and Services: The report provides the bifurcation of the market into three segments based on the product and services: Services, Consumables, and Equipment. In 2021, the services held the share of more than 80% in the market, whereas, the consumables are expected to be the fastest growing segment with a CAGR of around 5.4% in the forecasted period owing to an increase in the number of people receiving dialysis treatment due to favorable reimbursement systems, the development of improved products, and improved healthcare infrastructure.

By Type: The report further provides the segmentation based on the type: Hemodialysis and Peritoneal Dialysis. The hemodialysis segment held the highest share of around 90% in the market. The market’s expansion is aided by the rise in the incidence of kidney failure and end-stage renal disease (ESRD).

By End-User: The report provides an analysis of the market based on end-user: In-Center Dialysis and Home Dialysis. The home dialysis segment is expected to be the highest-growing segment with a CAGR of approx. 4.7% in the forecasted period. From the safety point of view and owing to the continuous advancement in technology, a paradigm shift towards home dialysis treatments & telehealth is expected to better respond to chronic kidney disease (CKD) patients’ needs in the near and long term.

By Number of Patients: The report also provides a glimpse of the number of dialysis patients. The population of patients receiving dialysis continues to grow rapidly as a result of an increase in the availability of dialysis, population aging, increased prevalence of hypertension and diabetes mellitus, and toxic environmental exposures. The dialysis patients have been analyzed based on type: Hemodialysis and Peritoneal Dialysis. Almost 89% of the patients received hemodialysis in 2021, while the remaining patients received peritoneal dialysis. The dialysis patients have also been segmented based on the region: Asia Pacific, Europe, Middle East & Africa (EMEA), North America, and the Rest of the World. In 2021, the Asia Pacific has the highest number of patients receiving dialysis, followed by the EMEA region.

By Region: The report provides insight into the dialysis market based on the regions namely North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the major share of around two-fifths in the market, owing to the favorable reimbursement scenario, and increasing demand for dialysis in the treatment of chronic and acute renal diseases owing to the dearth of kidney donors. Within North America, the US is leading the market owing to an increasing number of kidney diseases. According to CDC, more than 1 in 7 US adults are estimated to have chronic kidney disease (CKD). The US dialysis market is further analyzed based on product and services (Services, Consumables, and Equipment), type (Hemodialysis and peritoneal dialysis), and end-user (In-Center Dialysis and Home Dialysis).

The European dialysis market is further studied based on products and services: Services, Consumables, and Equipment. In 2021, services held the major share of the market whereas consumables held the highest CAGR of around 8% of the market.

The Asia Pacific’s dialysis market has been bifurcated based on the following region: China, Japan, Australia, India, South Korea, and the Rest of the Asia Pacific. China held a major share of around 30% in Asia Pacific’s dialysis market in 2021, owing to the rising diabetic population. According to the International Diabetes Federation, the number of diabetic people is expected to increase to 174.43 million by the year 2045. On the other hand, India is expected to be the fastest-growing region.

Market Dynamics:

Growth Drivers: The global dialysis market has been growing over the past few years, due to factors such as increasing diabetic population, increasing health spending, higher prevalence among aging population, increasing consumption of alcohol, increasing cases of ESRD, and many other factors. The aging population is one of the main drivers of growth in the global dialysis market. The aging population is more prone to chronic kidney disease because it is associated with serious diseases such as diabetes, cardiovascular disease, stroke, and arthritis, which would create opportunities for dialysis market growth.

Challenges: However, the market growth would be negatively impacted by various challenges such as high treatment costs, stringent regulations, etc.

Trends: The market is projected to grow at a fast pace during the forecast period, due to various latest trends such as technological advancements, preference for dialysis treatment over transplant, rising demand for home dialysis, etc. A patient’s quality of life increases when he or she can dialyze from home, especially in terms of improved independence and the capacity to work. Working allows dialysis patients to have more financial flexibility and psychological well-being, which is especially important for roughly half of new end-stage renal disease (ESRD) patients who are of working age. Therefore, the preference for home dialysis is expected to be increasing in the forthcoming years.

Impact Analysis of COVID-19 and Way Forward:

COVID-19 has had a positive impact on the growth of the dialysis market as patients are required to continue with their dialysis schedule amid of pandemic also. Moreover, the gradual shift towards home hemodialysis treatment before the pandemic and the concerns over the spread of COVID-19 infection have considerably accelerated patient interest in home hemodialysis treatment. Also, technological advancement during the pandemic has boosted the market and is expected to continue to do so in the coming years. For instance, starting in 2021, customers have benefited from the virtual reality (VR) tool, staysafe MyTraining VR (launched by Fresenius Medical Care), to support patient training for continuous ambulatory peritoneal dialysis (CAPD).

Competitive Landscape:

The global dialysis market is consolidated. The key players in the global dialysis market are:

Fresenius Medical Care AG & Co. KGaA
Medtronic Plc
Becton, Dickinson and Company (C.R. Bard, Inc.)
Nipro Corporation
B. Braun (B. Braun Avitum AG)
Baxter International, Inc.
DaVita Inc.
Asahi Kasei Corporation
Nikkiso Co. Ltd.
Toray Industries, Inc.
AngioDynamics, Inc.
Quanta Dialysis Technologies Ltd.
Diaverum

Some of the strategies among key players in the market are product launches, mergers, acquisitions, and collaborations. For instance, in 2022, DaVita Inc. and Medtronic plc announced the intent to form a new, independent kidney care-focused medical device company (NewCo) to enhance the patient treatment experience and improve overall outcomes. Whereas, Baxter International Inc. announced the US Food and Drug Administration (FDA) 510(k) clearance of the company’s ST Set used in continuous renal replacement therapy (CRRT). Moreover, In 2021, Fresenius Medical Care was the major shareholder in the global hemodialysis product market with a share of more than 40%. Whereas, Baxter International was the major shareholder in the global peritoneal dialysis product market with more than 74% share in the market.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Home Dialysis Systems Market Research Report by Product, Dialysis Type, Disease Treatment Type, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • $ 3949
  • January 2023
  • 253 pages

Home Dialysis Systems Market Research Report by Product (Consumables and Device), Dialysis Type, Disease Treatment Type, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation ...

  • World
  • Marketing Research
  • Chronic Disease
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on